Die genetische Testung ist der Myokardbiopsie bei Kardiomyopathien überlegen – pro

Schlüsselwörter

Genetische Testung - Next-Generation Sequencing - Dilatative Kardiomyopathie (DCM) - Hypertrophische Kardiomyopathie (HCM)

Keywords

genetic testing - Next-Generation Sequencing - dilated cardiomyopathy - hypertrophic cardiomyopathy

• Literatur

• 1 Charron P et al. Genetic counselling and testing in cardiomyopathies. Eur Heart J 2010; 31: 2715-2726
• 2 Gersh BJ et al. 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. J Am Coll Cardiol 2011;
• 3 Kuhl U, Schultheiss HP. Myocarditis. Dtsch Arztebl Int 2012; 109: 361-368
• 4 McMurray JJ et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33: 1787-1847
• 5 Meder B et al. Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet 2011; 4: 110-122
• 6 Meune C et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006; 354: 209-210
• 7 van Berlo JH et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations. J Mol Med (Berl) 2005; 83: 79-83
• 8 van Rijsingen IA et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 2012; 59: 493-500
• 9 Yilmaz A et al. Comparative evaluation of left and right ventricular endomyocardial biopsy. Circulation 2010; 122: 900-909